Novo A/S »

Metagenomi shares owned by Novo A/S

Quarter-by-quarter ownership of Metagenomi (MGX) shares owned by Novo A/S from 13F filings

Historical chart of Novo A/S investment in Metagenomi

Tip: Access up to 7 years of quarterly data

All positions including Metagenomi held by Novo A/S consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Metagenomi by Novo A/S

Quarter filed Position value Share count Share price at filing
2024-06-30 $7.3M 1.8M 4.08
2024-03-31 $18M 1.7M 10.55

More positions owned by Novo A/S

Vanguard Index Fds Total Stk Mkt (VTI)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Tempus Ai Cl A
Asml Holding N V N Y Registry Shs (ASML)
salesforce (CRM)
Edgewise Therapeutics (EWTX)
Corcept Therapeutics Incorporated (CORT)
Vaxcyte (PCVX)
Insmed Com Par $.01 (INSM)
Mirum Pharmaceuticals (MIRM)
Crinetics Pharmaceuticals In (CRNX)
Cable One (CABO)
BioMarin Pharmaceutical (BMRN)
Merus N V (MRUS)
Apple (AAPL)

View all positions for Novo A/S

Top funds holding Metagenomi

Novo A/S
RA Capital Management
Farallon Capital Management
Partner Fund Management
Hillhouse Capital Advisors
Citadel Advisors
Eventide Asset Management
Deep Track Capital
Pura Vida Investments
BlackRock
Millennium Management
Artal Group
Frazier Life Sciences Management
ExodusPoint Capital Management
Vanguard Group

View all funds holding Metagenomi